Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rhian Gabe

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Thorax|January 27, 2026
Frailty, comorbidity and survival comparisons between populations eligible for screening according to risk factor versus risk score criteria: results from the Yorkshire Lung Screening TrialAnas Almatrafi, Rhian Gabe, Rebecca J Beeken, et al.
Plos Neglected Tropical Diseases|May 13, 2017
A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KHMohamed Osman, Anoop Mistry, Ada Keding, et al.
Lancet (London, England)|January 24, 2017
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory studyHashim U Ahmed, Ahmed El-Shater Bosaily, Louise C Brown, et al.
BJGP Open|June 16, 2026
Targeted Prostate Health Checks for prostate cancer in men at high risk: a feasibility pilot in primary and secondary care in North East LondonMuhammad Haider, Apple Dumagat, James Sa Green, et al.
Addiction (Abingdon, England)|April 21, 2018
The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trialOmara Dogar, Deepa Barua, Melanie Boeckmann, et al.
The Lancet. Oncology|May 20, 2017
Effect of second timed appointments for non-attenders of breast cancer screening in England: a randomised controlled trialPrue C Allgood, Roberta Maroni, Sue Hudson, et al.
BMJ Open|January 25, 2025
Protocol for a systematic review and individual participant data meta-analysis for risk factors for lung cancer in individuals with lung nodules identified by low-dose CT screeningPanos Alexandris, Samantha Quaife, Christine D Berg, et al.
Health Technology Assessment (Winchester, England)|September 23, 2014
VenUS IV (Venous leg Ulcer Study IV) - compression hosiery compared with compression bandaging in the treatment of venous leg ulcers: a randomised controlled trial, mixed-treatment comparison and decision-analytic modelRebecca L Ashby, Rhian Gabe, Shehzad Ali, et al.
ESC Heart Failure|August 8, 2019
Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo-controlled trialMiriam J Johnson, Sarah Cockayne, David C Currow, et al.
The Lancet. Global Health|October 18, 2020
Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trialOmara Dogar, Ada Keding, Rhian Gabe, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Thorax|January 27, 2026
Frailty, comorbidity and survival comparisons between populations eligible for screening according to risk factor versus risk score criteria: results from the Yorkshire Lung Screening TrialAnas Almatrafi, Rhian Gabe, Rebecca J Beeken, et al.
Plos Neglected Tropical Diseases|May 13, 2017
A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KHMohamed Osman, Anoop Mistry, Ada Keding, et al.
Lancet (London, England)|January 24, 2017
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory studyHashim U Ahmed, Ahmed El-Shater Bosaily, Louise C Brown, et al.
BJGP Open|June 16, 2026
Targeted Prostate Health Checks for prostate cancer in men at high risk: a feasibility pilot in primary and secondary care in North East LondonMuhammad Haider, Apple Dumagat, James Sa Green, et al.
Addiction (Abingdon, England)|April 21, 2018
The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trialOmara Dogar, Deepa Barua, Melanie Boeckmann, et al.
The Lancet. Oncology|May 20, 2017
Effect of second timed appointments for non-attenders of breast cancer screening in England: a randomised controlled trialPrue C Allgood, Roberta Maroni, Sue Hudson, et al.
BMJ Open|January 25, 2025
Protocol for a systematic review and individual participant data meta-analysis for risk factors for lung cancer in individuals with lung nodules identified by low-dose CT screeningPanos Alexandris, Samantha Quaife, Christine D Berg, et al.
Health Technology Assessment (Winchester, England)|September 23, 2014
VenUS IV (Venous leg Ulcer Study IV) - compression hosiery compared with compression bandaging in the treatment of venous leg ulcers: a randomised controlled trial, mixed-treatment comparison and decision-analytic modelRebecca L Ashby, Rhian Gabe, Shehzad Ali, et al.
ESC Heart Failure|August 8, 2019
Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo-controlled trialMiriam J Johnson, Sarah Cockayne, David C Currow, et al.
The Lancet. Global Health|October 18, 2020
Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trialOmara Dogar, Ada Keding, Rhian Gabe, et al.
Pageof 9